Related Experiment Video
Updated: Jul 15, 2026
23:53
Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
Towards stem cell based therapies for Parkinson's disease
1Department of Experimental Medical Science, Wallenberg Neuroscience Center, Division of Neurobiology and Lund Stem Cell Center, Lund University, BMC A11, S-221 84 Lund, Sweden malin.parmar@med.lu.se.
Development (Cambridge, England)
|January 10, 2018
Summary
Cell transplantation offers hope for neurodegenerative diseases like Parkinson's. Researchers are now generating therapeutic dopamine neurons from stem cells, moving closer to clinical trials.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Cell Therapy
Background:
- Cell transplantation, particularly using fetal-derived dopamine neuron progenitors, has shown promise for Parkinson's disease.
- Limitations of fetal tissue include scarcity, variability, and ethical considerations.
- The need for scalable and reliable cell sources has driven research into alternatives.
Purpose of the Study:
- To explore scalable sources for therapeutic cells for neurodegenerative diseases.
- To advance the generation of authentic midbrain dopaminergic neurons from pluripotent stem cells.
- To pave the way for upcoming clinical trials using stem cell-derived therapies.
Main Methods:
- Investigating stem cell-based approaches for cell generation.
- Developing methods for reprogramming cells into therapeutic neuronal types.
- Generating authentic midbrain dopaminergic neurons from pluripotent stem cells.
Main Results:
- Established protocols for generating authentic midbrain dopaminergic neurons from pluripotent stem cells.
- Overcame limitations associated with fetal-derived cell transplantation.
- Demonstrated the potential for scalable production of therapeutic cells.
Conclusions:
- Pluripotent stem cells offer a viable and scalable alternative to fetal tissue for cell transplantation therapies.
- Advancements in generating specific neuronal subtypes are crucial for treating neurodegenerative conditions.
- Clinical trials utilizing stem cell-derived dopaminergic neurons are on the horizon, offering new therapeutic possibilities.
More Related Videos
12:13Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies
Published on: July 11, 2019
09:44Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
Published on: May 2, 2025
Related Concept Videos
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...